Contact us

SeqOne S.A.S

Address
SeqOne S.A.S.
22 Rue Durand
34000 Montpellier, France
Contact
Pauline
+33 (0) 9 54 40 42 84
contact@seq.one

A French start-up harnesses the power of the latest generation genomic sequencers to dramatically increase COVID 19 testing capacity

SeqOne Genomics, a start-up specialized in genomic analysis software, is partnering with leading medical testing labs to develop an approach that delivers up to 100 times more COVID 19 tests per machine thanks to NGS sequencers. Montpellier: May 1st, 2020: Epidemiological experts agree that the key to successfully managing the COVID 19 pandemic is a […]

> Read the full article here

EUROFINS BIOMNIS AND SEQONE PARTNER TO IMPROVE CLINICAL ACCESS TO WHOLE EXOME TESTING

Eighty percent of rare diseases are genetic in origin and result from a small number of genetic mutations. Identifying these variations is essential in diagnosing the diseases and can dramatically improve patient care. Making Whole Exome sequencing more affordable to improve diagnostic efficiency Since 2017, Eurofins Biomnis has offered “Whole Exome” sequencing which, starting from […]

> Read the full article here

SeqOne raises €3m to accelerate the adoption of genetic testing in healthcare

SeqOne announces a three million euro funding round led by Elaia with IRDI / SORIDEC and supported by BPI France.  The funding will accelerate the development of SeqOne’s genetic analysis platform combining AI and big data approaches to  make genetic analysis more accessible to doctors treating cancer and hereditary diseases. [Dateline: Montpellier 28/03/2019]  Chronic conditions […]

> Read the full article here

Canadian and French startups announce genomics partnership to better diagnose rare disease

  February 28th, 2018: Paris, France & Toronto, Canada Gene42 Inc., a Toronto company that develops software for precision medicine, and SeqOne, a French life science company providing genomic data analysis solutions for healthcare, announced their partnership to accelerate rare disease diagnosis. There are roughly 7,000 rare diseases, with patients waiting on average 5–7 years […]

> Read the full article here

SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare

Montpellier 12th of July, 2017:  SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology.  i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking […]

> Read the full article here

Next generation genomic analysis for next generation healthcare